Drug Shortage Report for XIGDUO
| Report ID | 154677 |
| Drug Identification Number | 02449935 |
| Brand name | XIGDUO |
| Common or Proper name | dapagliflozin and metformin hydrochloride tablets |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE DAPAGLIFLOZIN |
| Strength(s) | 850MG 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 6 blisters (10 tablets per blister) per carton |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-02-21 |
| Actual start date | |
| Estimated end date | 2022-02-22 |
| Actual end date | 2022-02-22 |
| Shortage status | Resolved |
| Updated date | 2022-02-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-02-23 | English | Compare |
| v7 | 2022-02-22 | French | Compare |
| v6 | 2022-02-22 | English | Compare |
| v5 | 2022-02-22 | English | Compare |
| v4 | 2022-02-14 | French | Compare |
| v3 | 2022-02-14 | English | Compare |
| v2 | 2022-02-10 | French | Compare |
| v1 | 2022-02-10 | English | Compare |
Showing 1 to 8 of 8